TOP1 and breast cancer: We describe here, using the example of repurposing of Top1 inhibitors for the treatment of breast cancer, our approach to identify novel therapeutic indications for standard chemotherapeutic agents, based on prior knowledge of the pharmacology of these agents and exploratory studies for biomarker establishment.